Finnrick - Ensuring a Safer and More Transparent Supply Chain
NUPEPS Peptides

NUPEPS Peptides

Ipamorelin

Finnrick tested 2 samples of Ipamorelin (GHS agonist) from NUPEPS Peptides between 16 Dec 2025 and 18 Dec 2025. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).

Finnrick Rating™
Tentative Rating
NUPEPS Peptides
Ipamorelin
Tested 2 Samples
Last test 18 Dec 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Ipamorelin tests from NUPEPS Peptides

Samples are tested in commercial labs

Tests Count

2

Scores

AVG8.6MIN8.0MAX9.2

Last

18 Dec 2025

First

16 Dec 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
18 Dec 2025View8.05mg4.5mg-10.0%99.70%I720250915-5White Label / Silver Crimp / Clear Red Cap Lab GVendor
16 Dec 2025View9.25mg4.7mg-6.0%99.70%I720250915-5White Label / Silver Crimp / Clear Red Cap Lab GVendor

Launch with Finnrick

Some of the samples listed on this page were submitted by their vendor, as part of the Launch with Finnrick vendor support program.

The program is designed to help vendors get listed on the Finnrick web site while protecting the integrity of our rating system.

The vendor submitted four samples per product, two of which were tested by Finnrick for identity, purity and quantity according to our usual process. The vials were anonymized before being sent to the testing lab.